No other disclosures were reported.įunding/Support: This study was supported by grants R01MH117014 (Dr Moore), K23MH120437 (Dr Barzilay), and R21MH123916 (Dr Barzilay) from the National Institute of Mental Health (NIMH) and the Lifespan Brain Institute of Children’s Hospital of Philadelphia and Penn Medicine, University of Pennsylvania. Dr Barzilay reported owning stock in Taliaz Health and serving on the scientific boards of Taliaz Health and Zynerba Pharmaceuticals outside the submitted work. ![]() Supervision: Brunstein Klomek, Moore, Argabright, Barzilay.Ĭonflict of Interest Disclosures: Mrs Visoki reported that her spouse is a shareholder in and executive of Kidas, with no conflict of interest relevant to this work. Statistical analysis: Visoki, Moore, Argabright, Barzilay.Īdministrative, technical, or material support: Moore, Argabright, DiDomenico, Benton. Ms Arnon and Dr Brunstein Klomek contributed equally to this work.Ĭoncept and design: Arnon, Brunstein Klomek, Argabright, Barzilay.Īcquisition, analysis, or interpretation of data: Visoki, Moore, Argabright, DiDomenico, Benton, Barzilay.ĭrafting of the manuscript: Arnon, Brunstein Klomek, Barzilay.Ĭritical revision of the manuscript for important intellectual content: All authors. ![]() ![]() Corresponding Author: Ran Barzilay, MD, PhD, Hospital of the University of Pennsylvania, 34th and Spruce St, Gates Building, 10th Floor, Philadelphia, PA 19104 ( or Contributions: Mrs Visoki and Dr Barzilay had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |